middle.news
Nova Eye Medical’s Q1 Revenue Climbs 20%, Eyes Breakeven by Mid-2026
12:01pm on Wednesday 5th of November, 2025 AEDT
•
Healthcare
Read Story
Nova Eye Medical’s Q1 Revenue Climbs 20%, Eyes Breakeven by Mid-2026
12:01pm on Wednesday 5th of November, 2025 AEDT
Key Points
Q1 FY26 revenue of US$7.47 million, up 20% year-on-year
FY26 sales guidance confirmed at US$21-24 million excluding China
On track for breakeven EBITDA by June 2026, delayed to H2 due to slower Q1 sales
New clinical study supports safety and efficacy of iTrack Advance device
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nova Eye Medical (ASX:EYE)
OPEN ARTICLE